We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Rise in Class I Recalls Reflects A Fundamental Policy Shift at FDA
Rise in Class I Recalls Reflects A Fundamental Policy Shift at FDA
January 17, 2007
The FDA's decision to issue 45 Class I recalls over the past fiscal year signals a fundamental shift in enforcement policy for an agency still reeling from criticism over recent drug safety incidents, experts say.